Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for reducing the transfer of pathogenic microorganisms

A technology of pathogenic microorganisms and microorganisms, applied in the direction of microorganism-based methods, microorganisms, microorganisms, etc., can solve problems such as the difficulty in determining the source of MRSA infection strains

Pending Publication Date: 2021-07-30
拉克托拜欧有限公司
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Recently, hybridization of different CA-MRSA and HA-MRSA strains has been observed, which often makes it difficult to determine the source of the infecting MRSA strain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for reducing the transfer of pathogenic microorganisms
  • Method for reducing the transfer of pathogenic microorganisms
  • Method for reducing the transfer of pathogenic microorganisms

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0233] Example 1 strain screening and identification

[0234] sample

[0235] In order to identify and select bacterial strains according to the invention, a strain collection of lactic acid bacteria (LAB) was established. Samples from different sources such as homemade sauerkraut, kimchi and healthy human donor samples (vaginal, oral, anal, skin) were collected to isolate at least 995 species of lactic acid bacteria. Samples were collected in Man Rogosa Sharp (MRS, Sigma-Aldrich) broth and agar and incubated anaerobically at 37°C overnight or until colonies formed. Isolates were plated and subcultured until pure colonies were obtained. Pure colonies were stored in MRS broth with 25% glycerol at -80 °C for future use. Strains were identified using standard methods of 16SrRNS Sanger sequencing.

Embodiment 2

[0236] Example 2: Co-culture Assay / Competition Assay

[0237] Competition between bacterial strains and Staphylococcus aureus was identified (Dowarah, R., et al. 2018, Selection and characterization of probiotic lactic acid bacteria and its impact on growth, nutrient digestibility, health and antioxidant status inweaned piglets.PLoS ONE, 13(3), Khare, A., & Tavazoie, S. (2015). Multifactorial Competition and Resistance in a Two-Species Bacterial System. PLoS Genetics, 11(12), 1–21.).

[0238] S. aureus subsp. aureus COL (CCOS461), S. aureus CC398 (SSI strain 08S00974) and S. aureus US300 (ATCC BAA-1717) were used as MRSA test organisms. Staphylococcus aureus was cultured in brain heart infusion (BHI) broth.

[0239] Overnight cultures of S. aureus and isolates were adjusted to an optical density at 600 nm (OD600) of 1 and harvested by centrifugation (6.000 rpm for 2 minutes). Cell pellets were washed twice in phosphate buffered saline (1×PBS) and then resuspended in 1×PBS. ...

Embodiment 3

[0241] Example 3: Determining transfers between objects

[0242]The transfer of pathogenic bacteria between two subjects was determined by a co-culture assay. Overnight cultures of Staphylococcus aureus and bacterial strain isolates were adjusted for cell density to an optical density at 600 nm (OD600) of 1 and harvested by centrifugation (6.000 rpm for 2 minutes). Wash the cell pellet twice in phosphate-buffered saline (1×PBS), and resuspend in 1×PBS to make the cell concentration approximately 1×10 4 CFU / ml. The two cell suspensions were mixed 1:1, and 0.2 ml was spread on a BHI agar plate and allowed to dry in sterile air for 5 minutes. Monocultures of MRSA and LAB were used as controls, and for control plates, the cell suspension was mixed 1:1 with sterile PBS buffer, 0.2 ml was spread on BHI agar plates, and allowed to dry in sterile air for 5 min .

[0243] 5 ml sterile PBS was absorbed through a sterile round filter (D 9 cm) type A.G.F 118 and placed on top of the a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a composition comprising at least one lactic acid bacterium for use in decreasing the transfer of a pathogenic microorganism between a surface of a first subject and a surface of a second subject.

Description

technical field [0001] The invention relates to a method for transferring pathogenic microorganisms. In particular, the invention relates to the transfer of pathogenic microorganisms between the surface of a first object and the surface of a second object. Background technique [0002] Pathogenic microorganisms are microorganisms that can cause the development of disease in mammals and can include bacterial microorganisms; viral microorganisms; fungal microorganisms; parasitic microorganisms; and algal microorganisms. Gram-positive bacteria, Staphylococcus aureus, are among the most common human pathogens. [0003] With the discovery of penicillin in 1928 and its mass production in the early 1940s, S. aureus infections were almost treatable without any major complications. However, clinicians soon observed the emergence of penicillin-resistant S. aureus strains, largely due to the expression of the bacteria's β-lactamases, which destroy penicillin and cephalosporin antibio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/744A61P31/00A61K45/06A61L2/00A61K8/99A01N63/00A61Q17/00
CPCA61P31/00A61K35/744A61K45/06A61K8/99A01N63/22A01N63/20A61Q17/005A61K2800/84A61K2800/92C12N1/20C12R2001/225C12N1/205C12R2001/01C12R2001/25A61K2300/00A61P31/04A61K35/747
Inventor C·维德尔I·B·乔根森S·克雅鲁夫
Owner 拉克托拜欧有限公司